These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3614812)

  • 1. Serum copper and zinc levels in premalignant and malignant lesions of the oral cavity.
    Varghese I; Sugathan CK; Balasubramoniyan G; Vijayakumar T
    Oncology; 1987; 44(4):224-7. PubMed ID: 3614812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.
    Rajendran R; Remani P; Vijayakumar T; Vasudevan DM
    Ann Dent; 1990; 49(1):36-8, 51. PubMed ID: 2346298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum beta 2-microglobulin in premalignant and malignant lesions of the oral cavity.
    Anil S; Beena VT; Nair RG; Vijayakumar T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jun; 79(6):750-2. PubMed ID: 7621034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress.
    Rai B; Kaur J; Jacobs R; Singh J
    J Oral Sci; 2010 Jun; 52(2):251-6. PubMed ID: 20587949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer.
    Sawhney H; Kumar CA
    Cancer Biomark; 2011-2012; 10(1):43-9. PubMed ID: 22297551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer.
    Rajpura KB; Patel PS; Chawda JG; Shah RM
    J Oral Pathol Med; 2005 May; 34(5):263-7. PubMed ID: 15817068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of serum copper, iron and immune complexes in potentially malignant disorders and oral cancer.
    Tiwari R; David CM; Mahesh DR; Sambargi U; Rashmi KJ; Benakanal P
    Braz Oral Res; 2016 Oct; 30(1):e101. PubMed ID: 27737355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of copper, zinc, iron and ceruplasmin in oral leukoplakia and squamous cell carcinoma.
    Jayadeep A; Raveendran Pillai K; Kannan S; Nalinakumari KR; Mathew B; Krishnan Nair M; Menon VP
    J Exp Clin Cancer Res; 1997 Sep; 16(3):295-300. PubMed ID: 9387904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and salivary interleukin-1β level in oral precancer: An observational study.
    Selvan TT; Patil RK; Singh V; Verma S; Tripathi A; Khanna V; Chaurasia A; Shetye AG
    J Cancer Res Ther; 2024 Apr; 20(3):788-792. PubMed ID: 39023584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How to improve the diagnostic and therapeutic levels of oral premalignant lesions].
    Zhou ZT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):89-91. PubMed ID: 15842851
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of role of ceruloplasmin in oral potentially malignant disorders and oral malignancy-A cross-sectional study.
    Shah PH; Venkatesh R; More CB
    Oral Dis; 2017 Nov; 23(8):1066-1071. PubMed ID: 28513913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of serum copper and zinc levels in oral submucous fibrosis: an atomic absorption spectroscopic study.
    Neethi H; Patil S; Rao RS
    J Contemp Dent Pract; 2013 Sep; 14(5):801-5. PubMed ID: 24685778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of premalignant lesions and early cancers of the oral cavity.
    Gillenwater AM; Chambers MS
    Tex Dent J; 2006 Jun; 123(6):512-20. PubMed ID: 16875018
    [No Abstract]   [Full Text] [Related]  

  • 14. Trace elements (copper, zinc, selenium and molybdenum) as markers in oral sub mucous fibrosis and oral squamous cell carcinoma.
    Khanna S; Udas AC; Kumar GK; Suvarna S; Karjodkar FR
    J Trace Elem Med Biol; 2013 Oct; 27(4):307-11. PubMed ID: 23664922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum mRNA levels of cytokeratin-19 and vascular endothelial growth factor in oral squamous cell carcinoma and oral potentially malignant disorders using RT-PCR.
    Senevirathna K; Mahakapuge TAN; Jayawardana NU; Rajapakse J; Gamage CU; Seneviratne B; Perera U; Kanmodi KK; Jayasinghe R
    BMC Oral Health; 2024 Sep; 24(1):1062. PubMed ID: 39261828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer.
    Raval GN; Patel DD; Parekh LJ; Patel JB; Shah MH; Patel PS
    Oral Dis; 2003 May; 9(3):119-28. PubMed ID: 12945593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions.
    Patel PS; Shah MH; Jha FP; Raval GN; Rawal RM; Patel MM; Patel JB; Patel DD
    Indian J Cancer; 2004; 41(1):25-31. PubMed ID: 15105576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomorphometric analysis of oral submucous fibrosis and leukoplakia using methyl green-pyronin Y, Feulgen staining and exfoliative brush cytology.
    Metgud R; Gupta K; Prasad U; Gupta J
    Biotech Histochem; 2015 Jan; 90(1):8-13. PubMed ID: 24867495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of iron and proteins in oral submucous fibrosis (OSMF).
    Rajendran R; Vasudevan DM; Vijayakumar T
    Ann Dent; 1990; 49(2):23-5, 45. PubMed ID: 2278476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A community-based RCT for oral cancer screening with toluidine blue.
    Su WW; Yen AM; Chiu SY; Chen TH
    J Dent Res; 2010 Sep; 89(9):933-7. PubMed ID: 20525960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.